RA

NYSETaxable Bonds

Brookfield Real Assets Income Fund

Sponsor: Brookfield · Inception Dec 2, 2016 · Pays monthly

Market priceShare price

$11.66

+2.01% (+$0.23)

NAVAsset value per share

$13.32

as of Oct 13, 2026 · Nasdaq NAV symbol

Premium / discountPrice vs. assets

12.46% discount *

Indicative: latest price vs latest reported NAV

Distribution rate (price)Payout rate

12.14%

regular, annualised · on NAV 10.63%

Expense ratioAnnual cost

Not reported

no tagged fee table

LeverageBorrowing

20.4%

of total managed assets

Quote status: Market closed — last regular-session price · last trade Oct 15, 2026, 4:00 PM EDT (exchange time, ET) · retrieved Oct 15, 2026, 5:46 PM EDTRegular-session prices; extended-hours quotes are not displayed.

From the wire

News mentioning RA

10 headlines

Taxable Bonds

New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease

New SKYRIZIÂ (risankizumab-rzaa) and RINVOQÂ (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel DiseasePR NewswireNOR

GuruFocus · Oct 11 · 14:00 UTC ↗

RA · Taxable Bonds

Brookfield Real Assets Income Fund Inc. (NYSE:RA) Shareholders Set to Receive $0.12 Monthly Dividend

Defense World · Oct 7 · 07:31 UTC ↗ · RA · Taxable Bonds

AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress

GuruFocus · Sep 30 · 02:00 UTC ↗ · RA · Taxable Bonds

Brookfield Real Assets Income Fund (NYSE:RA) Stock Sale Disclosed by Rep. Kevin Hern

Defense World · Sep 29 · 05:03 UTC ↗ · RA · Taxable Bonds

Brookfield Real Assets Income Fund Inc. Declares Q4 2026 Distribution Schedule

GlobeNewsWire · Sep 25 · 17:04 UTC ↗ · RA · Taxable Bonds

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis

GuruFocus · Sep 22 · 03:00 UTC ↗ · RA · Taxable Bonds

Short Interest in Brookfield Real Assets Income Fund Inc. (NYSE:RA) Drops By 36.8%

Defense World · Aug 31 · 02:21 UTC ↗ · RA · Taxable Bonds

LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board of Directors

Business Wire · Jul 27 · 10:00 UTC ↗ · RA · Taxable Bonds

RA: A Classic Fixed-Income CEF In 'Real Assets' Clothing

Seeking Alpha · Jul 27 · 04:10 UTC ↗ · RA · Taxable Bonds

Brookfield Real Assets Income Fund (NYSE:RA) Shares Cross Above 200 Day Moving Average – Here’s Why

Defense World · Jul 23 · 02:41 UTC ↗ · RA · Taxable Bonds

Headlines link to the original publisher; the publisher’s own image is shown where the feed supplies one. Syndicated duplicates are collapsed. Activist or governance items are shown as filed positions or proposals, not as inferred intent.

Data briefs for RA

Generated from this site’s own record of the fund: distributions, filings, portfolio reports and valuation against its own history. Labelled as ours, separate from external news.

RA trades 2.4σ below its own 1-year average

The closing price against NAV puts RA at a 13.1% discount, versus a 1-year average of a 9.7% discount. The Z-score says how unusual that is for this fund alone; it is not a valuation call, and discounts can stay wide.

CEF Explorer Data Desk · Oct 13, 2026 · Valuation

RA files N-PORT for Jun 30, 2026: 588 positions

Full portfolio as of month-end Jun 30, 2026, made public Aug 26, 2026. Weights are percent of net assets; compare with the prior report on the Holdings tab.

CEF Explorer Data Desk · Aug 26, 2026 · Holdings

Source filings

Shelf / offering registration filed · Apr 11, 2024
Shelf / offering registration filed · Apr 5, 2024
Shelf / offering registration filed · Jan 10, 2024
Shelf / offering registration filed · Apr 20, 2021
Shelf / offering registration filed · Dec 18, 2020

Distribution record

Every payment on record, the regular rate, and what reinvesting buys at today's discount.

Open →

Price vs. NAV

The full premium/discount history and where today sits against it.

Open →

CEF Explorer research page for Brookfield Real Assets Income Fund Inc.. Figures carry their own dates and sources; a discount to NAV does not guarantee convergence or any return. This is not investment advice.